| ALK | anaplastic lymphoma kinase |
| ANGPT | angiopoietin |
| ATC | anaplastic thyroid carcinoma |
| CTL | cytotoxic T lymphocyte |
| CTLA-4 | cytotoxic T lymphocyte antigen 4 |
| DCs | dendritic cell |
| DTC | differentiated thyroid carcinoma |
| ECM | extracellular matrix |
| EMT | epithelial-to-mesenchymal transition |
| FNA | fine-needle aspiration |
| FTC | follicular thyroid cancer |
| GM-CSF | granulocyte-macrophage colony-stimulating factor |
| HGF | hepatocyte growth factor |
| HTT | hyalinizing trabecular tumor |
| ICI | immune checkpoint inhibitor |
| IDO1 | indoleamine 2,3-dioxygenase 1 |
| IFN | interferon |
| ILC | innate lymphoid cell |
| INF | interferon |
| mAb | monoclonal antibody |
| MDSC | myeloid-derived suppressor cell |
| MMP | metalloproteinase |
| MNG | multinodular goiter |
| MTC | medullary thyroid cancer |
| NGS | next-generation sequencing |
| NK | natural killer |
| NKT | natural killer T cell |
| NLR | neutrophil-to-lymphocyte ratio |
| NSCLC | non-small-cell lung cancer |
| OS | overall survival |
| PD-1 | programmed cell death protein-1 |
| PD-L1 | programmed cell death ligand-1 |
| PDTC | poorly differentiated thyroid cancer |
| PMN | polymorphonuclear cell |
| PTC | papillary thyroid cancer |
| RET | REarranged during Transfection |
| RNS | reactive nitrogen species |
| ROS | reactive oxygen species |
| SCF | stem cell factor |
| TAM | tumor-associated macrophage |
| TAMC | tumor-associated mast cell |
| TAN | tumor-associated neutrophil |
| TC | thyroid cancer |
| TCR | T cell receptor |
| TDLN | tumor-draining lymph node |
| Tfh | T follicular helper cell |
| Th | T helper cell |
| TK | tyrosine kinase |
| TKI | tyrosine kinase inhibitor |
| TME | tumor microenvironment |
| TNF-α | tumor necrosis factor-α |
| Treg | regulatory T cell |
| VEGF | vascular endothelial growth factor |
| VEGFR | vascular endothelial growth factor receptor |